Medical Information Only. Consult your healthcare provider before enrolling in any clinical trial.
Alaska: below-average open trial sites
123 of 485 in-state trials are recruiting (25%); below the 37% national average by 12 percentage points.
According to ClinicalTrials.gov-derived indexes, Alaska sits in the lower half of US states by in-state trial count (#42 of 52 states by registered in-state trial count).
Alaska: 485 US clinical trials with in-state sites, 123 recruiting.
Alaska has 485 registered US clinical trials with a study site in-state, 123 of them currently recruiting (below the 37% national average by 12 percentage points). 217 of these trials are in Phase 3 (late-stage) and 158 in Phase 2. The most frequently studied condition in Alaska is Breast Cancer, with 22 linked trials.
Thin-volume Alaska archive
Alaska open-enrollment share is 25% (p6 of states with sites; national baseline 37%). Treat this page as a compact local index (thin-volume · low-open), then jump to recruiting trials or methodology rather than expecting hub-scale coverage.
Below-average open enrollment
Alaska still shows 123 recruiting of 485 in-state trials (25% open), but below the 37% national average by 12 percentage points, so archived statuses weigh heavier than the national baseline.
- 25%
- open (below national share)
- 123
- still recruiting despite cool share
- 158
- Phase 2 rows in this footprint
- 22
- top: Breast Cancer
Recruiting share is below the 37% national average by 12 percentage points. Counts include every study with at least one recorded site in the state. Registry reference only, not medical advice.
Alaska vs all states by indexed in-state trial count
Where this state's ClinicalTrials.gov site count sits among every state with at least one listed trial (coverage density, not care quality)
485 Top 81% more indexed trials than 19% of 52 states
States, banded by indexed in-state trial count
Each bar is a band; taller bars hold more states. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov · 2026-08-08
Key findings
What ClinicalTrials.gov does not surface for Alaska on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alaska open-enrollment share sits below the national baseline.
123 of 485 in-state trials (25.4%) are recruiting, against 37% nationally (-11.6 percentage points). Counts include every study with at least one recorded site in the state.
-
Anchorage dominates Alaska's trial geography.
Anchorage lists 438 of 485 in-state trials (90.3%) across 82 named facilities. Cities need five or more listed trials to appear here; locations are as filed by sponsors.
-
Breast Cancer is the most-studied condition in Alaska.
22 of 485 in-state trials (4.5%) list Breast Cancer. That is a local concentration figure, not a national disease ranking.
-
One sponsor accounts for a large share of Alaska trials.
National Cancer Institute (NCI) appears on 124 of 485 in-state trials (25.6%). Sponsor identity is as filed on ClinicalTrials.gov.
-
129 Alaska trials carry a completed status.
129 of 485 (26.6%) are completed. The open share above is the remainder that still lists recruiting.
By Status
| Status | Trial count |
|---|---|
| Active | 233 |
| Completed | 129 |
| Recruiting | 123 |
By Phase
| Phase | Trial count |
|---|---|
| Phase 3 | 217 |
| Phase 2 | 158 |
| NA | 43 |
| Phase 1 | 17 |
| Phase 4 | 10 |
Top Conditions
Top Sponsors
Where trials run in Alaska
Anchorage carries 438 of Alaska's 485 indexed trials (90%) across 82 named sites, ahead of Fairbanks at 130. 3 cities clear five listed trials, together naming 91 distinct sites.
| City | Trials | Listed sites |
|---|---|---|
| Anchorage | 438 | 82 |
| Fairbanks | 130 | 5 |
| Bethel | 5 | 4 |
Distinct trials and named sites per city, as filed with ClinicalTrials.gov; cities under five trials omitted. Vintage 2026-08-08.
Open-share low
Alaska open-enrollment share is 25% (p6 of states with sites; national baseline 37%).
Alaska: open share sits in the low tercile of states
Geography is concentrated: Anchorage alone accounts for 90% of Alaska's indexed trials (438 of 485), with Fairbanks a distant second at 130.
Phase mix: 217 Phase 3 vs 158 Phase 2 (balanced across stages).
Top condition: Breast Cancer (22 trials); top sponsor National Cancer Institute (NCI) (124).
thin-volume · low-open figures (485 trials · 25% open) describe registry geography under the open-share low read, not clinic capacity or protocol fit. Confirm status on ClinicalTrials.gov before acting.
States near Alaska on open-enrollment share
Cross-state peers under the open-share low read (thin-volume · low-open), not the same-state browse list.
Similar thin-volume peers (± open share)
- New Hampshire · 471 trials · 33% recruiting
- New Mexico · 579 trials · 29% recruiting
- Delaware · 652 trials · 33% recruiting
- Maine · 315 trials · 23% recruiting
- West Virginia · 277 trials · 36% recruiting
Similar low-open peers (± trial volume)
- Hawaii · 26% recruiting · 437 trials
- Idaho · 26% recruiting · 633 trials
- Nevada · 27% recruiting · 900 trials
- Mississippi · 27% recruiting · 500 trials
- Louisiana · 28% recruiting · 1,936 trials